Relationship between Expression of Plasma lncRNA-HEIH and Prognosis in Patients with Coronary Artery Disease

Table 2

Effect of lncRNA-HEIH on major clinical adverse events of CAD patients [ (%)].

Variable	High level ()	Low level ()
Cardiac adverse event ()	37 (35.92%)	5 (10.64%)	10.23	0.001
Death ()	14 (13.59%)	1 (2.13%)	4.713	0.038
Nonfatal myocardial infarction ()	11 (10.68%)	6 (12.77%)	0.14	0.783
Vascular reconstruction ()	18 (17.48%)	5 (10.64%)	1.162	0.336
Restenosis ()	11 (10.68%)	8 (17.02%)	1.173	0.297
First stenosis ()	4 (3.88%)	2 (4.26%)	0.012	1.000

.